Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1733-1748

  Wang, Xiaojia ^a   Podila, Ramakrishna ^a   Shannahan, Jonathan H ^a   Rao, Apparao M ^b   Brown, Jared M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

Graphene nanosheets; IL 33; Multiwalled carbon nanotubes; ST2; Th2 immune responses

Indexed keywords

CARBON NANOTUBE; DRUG CARRIER; GRAPHENE; GRAPHENE NANOSHEET; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN RECEPTOR; MESSENGER RNA; ST2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; INFLAMMATION; LUNG; LUNG LAVAGE; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHYSICAL CHEMISTRY; SPLEEN CELL; TH2 CELL;

GRAPHENE NANOSHEETS; IL-33; MULTIWALLED CARBON NANOTUBES; ST2; TH2 IMMUNE RESPONSES;

ADMINISTRATION, INTRAVENOUS; ANALYSIS OF VARIANCE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; GRAPHITE; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NANOSTRUCTURES; NANOTUBES, CARBON; RECEPTORS, INTERLEUKIN; TH2 CELLS;

MUS;

EID: 84877100531     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S44211     Document Type: Article

References (52)

1. Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urol Oncol. 2007;26(1):74-85.
2. Ji SR, Liu C, Zhang B, et al. Carbon nanotubes in cancer diagnosis and therapy. Biochim Biophys Acta. 2010;1806(1):29-35.
3. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun. 2010;34(3):J234-J246.
4. Grimm J, Scheinberg DA. Will nanotechnology influence targeted cancer therapy? Semin. Radiat Oncol. 2011;21(2):80-87.
5. Liu Z, Robinson JT, Tabakman SM, Yang K, Dai H. Carbon materials for drug delivery and cancer therapy. Mater Today. 2011;14(7-8):316-323.
6. Misra R, Acharya S, Sahoo SK. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today. 2010;15(19-20): 842-850.
7. Zhang Y, Bai Y, Yan B. Functionalized carbon nanotubes for potential medicinal applications. Drug Discov Today. 2010;15(11-12):428-435.
8. Nygaard UC, Hansen JS, Samuelsen M, Alberg T, Marioara CD, Løvik M. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicol Sci. 2009;109(1):113-123.
9. Mitchell LA, Lauer FT, Burchiel SW, McDonald JD. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol. 2009;4(7):451-456.
10. Yamaguchi A, Fujitani T, Ohyama K, et al. Effects of sustained stimulation with multi-wall carbon nanotubes on immune and inflammatory responses in mice. J Toxicol Sci. 2012;37(1):177-189.
11. Andersen AJ, Wibroe PP, Moghimi SM. Perspectives on carbon nanotube-mediated adverse immune effects. Adv Drug Deliv Rev. 2012;64(15):1700-1705.
12. Wang X, Katwa P, Podila R, et al. Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice. Part Fibre Toxicol. 2011;8:24.
13. Katwa P, Wang X, Urankar RN, et al. A carbon nanotube toxicity paradigm driven by mast cells and the IL-33/ST2 axis. Small. 2012;8(18): 2904-2912.
14. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5): 479-490.
15. Lloyd CM. IL-33 family members and asthma-bridging innate and adaptive immune responses. Curr Opin Immunol. 2010;22(6):800-806.
16. Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int. 2010;59(2):143-160.
17. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10(2): 103-110.
18. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007;282(36):26369-26380.
19. Yang Q, Li G, Zhu Y, et al. IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol. 2011;41(11):3351-3360.
20. Bihari P, Vippola M, Schultes S, et al. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol. 2008;5:14.
21. Moore TL, Pitzer JE, Podila R, et al. Multifunctional Polymer-Coated Carbon Nanotubes for Safe Drug Delivery. Particle and Particle Systems Characterization. 2013;30(4):365-373.
22. Wang H, Yang ST, Cao A, Liu Y. Quantification of carbon nanomaterials in vivo. Acc Chem Res. Epub October 4, 2012.
23. Mercer RR, Hubbs AF, Scabilloni JF, et al. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol. 2011;8:21.
24. Porter DW, Hubbs AF, Chen BT, et al. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology. Epub September 13, 2012.
25. Beamer CA, Girtsman TA, Seaver BP, et al. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology. Epub June 29, 2012.
26. Medepalli K, Alphenaar B, Raj A, Sethu P. Evaluation of the direct and indirect response of blood leukocytes to carbon nanotubes (CNTs). Nanomedicine. 2011;7(6):983-991.
27. Albini A, Mussi V, Parodi A, et al. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomedicine. 2010;6(2):277-288.
28. Murphy FA, Schinwald A, Poland CA, Donaldson K. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part Fibre Toxicol. 2012;9:8.
29. Rybak-Smith MJ, Sim RB. Complement activation by carbon nanotubes. Adv Drug Deliv Rev. 2011;63(12):1031-1041.
30. Bai Y, Zhang Y, Zhang J, et al. Repeated administrations of carbon nanotubes in male mice cause reversible testis damage without affecting fertility. Nat Nanotechnol. 2010;5(9):683-689.
31. Cherukuri P, Gannon CJ, Leeuw TK, et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci U S A. 2006;103(50):18882-18886.
32. Patlolla AK, Hussain SM, Schlager JJ, Patlolla S, Tchounwou PB. Comparative study of the clastogenicity of functionalized and nonfunctionalized multiwalled carbon nanotubes in bone marrow cells of Swiss-Webster mice. Environ Toxicol. 2010;25(6):608-621.
33. Zhang X, Yin J, Peng C, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 2011;49(3):986-995.
34. Jain S, Thakare VS, Das M, et al. Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density. Chem Res Toxicol. 2011;24(11):2028-2039.
35. Wu H, Liu G, Zhuang Y, et al. The behavior after intravenous injection in mice of multiwalled carbon nanotube/Fe3O4 hybrid MRI contrast agents. Biomaterials. 2011;32(21):4867-4876.
36. Murphy FA, Poland CA, Duffin R, Donaldson K. Length-dependent pleural inflammation and parietal pleural responses after deposition of carbon nanotubes in the pulmonary airspaces of mice. Nanotoxicology. Epub August 21, 2012.
37. Li M, Panagi Z, Avgoustakis K, Reineke J. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content. Int J Nanomedicine. 2012;7:1345-1356.
38. Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano. 2010;4(6):3181-3186.
39. Lacerda L, Herrero MA, Venner K, Bianco A, Prato M, Kostarelos K. Carbon-nanotube shape and individualization critical for renal excretion. Small. 2008;4(8):1130-1132.
40. Wang X, Reece SP, Brown JM. Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation. Toxicol Mech Methods. 2013;23(3):168-177.
41. Inoue K, Koike E, Yanagisawa R, Hirano S, Nishikawa M, Takano H. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol. 2009;237(3): 306-316.
42. Willart MA, Deswarte K, Pouliot P, et al. Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med. 2012;209(8):1505-1517.
43. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med. 2009;15(4): 410-416.
44. Wills-Karp M, Rani R, Dienger K, et al. Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J Exp Med. 2012;209(3):607-622.
45. Talabot-Ayer D, Calo N, Vigne S, Lamacchia C, Gabay C, Palmer G. The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters. J Leukoc Biol. 2012;91(1):119-125.
46. Matsuba-Kitamura S, Yoshimoto T, Yasuda K, et al. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis. Int Immunol. 2010;22(6):479-489.
47. Meisel C, Bonhagen K, Löhning M, et al. Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J Immunol. 2001;166(5):3143-3150.
48. Bonilla WV, Fröhlich A, Senn K, et al. The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science. 2012;335(6071): 984-989.
49. Trajkovic V, Sweet MJ, Xu D. T1/ST2-an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 2004;15(2-3): 87-95.
50. Germain RN. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol. 2002;2(5):309-322.
51. Mocan T, Iancu C. Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes. Int J Nanomedicine. 2011; 6:1945-1954.
52. Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine. 2011;6:2963-2979.